Contact
searchSearch
HMP Global

Peripheral Artery Disease (PAD) Topic Center

Features

CAse series
Intravascular Optical Coherence Tomography for the Diagnosis and Treatment of Peripheral Arterial Disease
04/04/2025
Mehmet Cilingiroglu, MD, FACC, FSCAI, FAHA, FESC, FACP; Thomas E. Milner, PhD; Ibrahim Halil Inanc, MD; Deniz Mutlu, MD; Konstantinos Marmagkiolis, MD, MBA, FACC, FSCAI; Cezar A. Iliescu, MD, FACC, FSCAI
In this case series, Cilingiroglu et al share their extensive experience in the use of OCT in daily clinical practice for PAD and CLTI cases as both a diagnostic and therapeutic tool.
In this case series, Cilingiroglu et al share their extensive experience in the use of OCT in daily clinical practice for PAD and CLTI cases as both a diagnostic and therapeutic tool.
In this case series,...
04/04/2025
Cath Lab Digest
Dr Ramon Varcoe
ISET 2025
The Role of Bioresorbable Stents in Tibial Disease: When and Where?
03/26/2025
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his...
03/26/2025
Vascular Disease Management
From Vascular Disease Management
Dr Babaev
ISET 2025
Thirty-Day Outcomes From the Disrupt PAD BTK II Study
01/31/2025
Anvar Babaev, MD, PhD
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD,...
01/31/2025
Vascular Disease Management
From Vascular Disease Management
Dr Kolluri
LINC 2025
The Case for Duplex Endpoints
01/29/2025
Raghu Kolluri, MS, MD, RVT, FSVM
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for...
01/29/2025
Vascular Disease Management
From Vascular Disease Management
Dr Halena
LINC 2025
“Yes, you can always cross”: Simplified Retrograde Access for Superficial Femoral Artery Occlusions
01/29/2025
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations,...
01/29/2025
Vascular Disease Management
From Vascular Disease Management
Case Report
Occluded Tibiopedal Access to Cross and Treat Complex Tibial Artery Occlusive Disease in a Patient With Critical Limb Ischemia
11/08/2024
Sreejit Nair, MD; Ashwani Sastry, MD; Janardhan Srinivasan, MD; Michael Canavan, DPM; Fadi Saab, MD, FACC, FSCAI; John H. Rundback, MD, FAHA, FSIR
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been...
11/08/2024
Vascular Disease Management
From Vascular Disease Management
Interview
The Economic Costs and Patient Consequences of Amputation as a Treatment for Critical Limb Ischemia
09/19/2024
Mary Yost, MBA, president and cofounder of The Yost Group, spoke with VDM about her AMP 2024 presentation on the consequences of amputation as a treatment for patients with CLI.
Mary Yost, MBA, president and cofounder of The Yost Group, spoke with VDM about her AMP 2024 presentation on the consequences of amputation as a treatment for patients with CLI.
Mary Yost, MBA, president and...
09/19/2024
Vascular Disease Management
From Vascular Disease Management
Dr Ramon Varcoe
AMP 2024
LIFE-BTK Further Analysis; 12-month RESOLV Data
09/18/2024
Ramon L. Varcoe, MBBS, MS, PhD
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP...
09/18/2024
Vascular Disease Management
From Vascular Disease Management
Dr Thomas Zeller
AMP 2024
SPORTS: Drug-Eluting Stent or Primary Bare Nitinol Stent Application vs Drug-Coated Balloons in Long SFA Lesions; HEAL Study Update
09/18/2024
Thomas Zeller, MD, PhD
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller...
09/18/2024
Vascular Disease Management
From Vascular Disease Management
Zola N'Dandu, MD
AMP 2024
Pooled Analysis of the DETOUR System; Risk Factors in CLI Patients That May Require DVA
09/17/2024
Zola N'Dandu, MD
In this video, Dr. Zola N'Dandu discusses two of his AMP 2024 presentations.
In this video, Dr. Zola N'Dandu discusses two of his AMP 2024 presentations.
In this video, Dr. Zola N'Dandu...
09/17/2024
Vascular Disease Management
From Vascular Disease Management
Chronic Limb-Threatening Ischemia (CLTI)
Treating a CTO of the SFA Using Auryon Laser Atherectomy in a CLTI Patient
08/31/2024
Nader Chadda, MD, FACC; IIyas Chadda
The patient is a 77-year-old man with diabetes mellitus, congestive heart failure, and abdominal aortic aneurysm status post repair with stent graft placement, who has been suffering from bilateral foot wounds that have been nonhealing. The...
The patient is a 77-year-old man with diabetes mellitus, congestive heart failure, and abdominal aortic aneurysm status post repair with stent graft placement, who has been suffering from bilateral foot wounds that have been nonhealing. The...
The patient is a 77-year-old man...
08/31/2024
Cath Lab Digest

Hear From the Experts

Dr Ramon Varcoe
ISET 2025
The Role of Bioresorbable Stents in Tibial Disease: When and Where?
03/26/2025
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his...
03/26/2025
Vascular Disease Management
Dr Babaev
ISET 2025
Thirty-Day Outcomes From the Disrupt PAD BTK II Study
01/31/2025
Anvar Babaev, MD, PhD
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD,...
01/31/2025
Vascular Disease Management
Dr Kolluri
LINC 2025
The Case for Duplex Endpoints
01/29/2025
Raghu Kolluri, MS, MD, RVT, FSVM
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for...
01/29/2025
Vascular Disease Management
Dr Halena
LINC 2025
“Yes, you can always cross”: Simplified Retrograde Access for Superficial Femoral Artery Occlusions
01/29/2025
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations,...
01/29/2025
Vascular Disease Management
Dr Ramon Varcoe
AMP 2024
LIFE-BTK Further Analysis; 12-month RESOLV Data
09/18/2024
Ramon L. Varcoe, MBBS, MS, PhD
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP...
09/18/2024
Vascular Disease Management
Dr Thomas Zeller
AMP 2024
SPORTS: Drug-Eluting Stent or Primary Bare Nitinol Stent Application vs Drug-Coated Balloons in Long SFA Lesions; HEAL Study Update
09/18/2024
Thomas Zeller, MD, PhD
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller...
09/18/2024
Vascular Disease Management
Zola N'Dandu, MD
AMP 2024
Pooled Analysis of the DETOUR System; Risk Factors in CLI Patients That May Require DVA
09/17/2024
Zola N'Dandu, MD
In this video, Dr. Zola N'Dandu discusses two of his AMP 2024 presentations.
In this video, Dr. Zola N'Dandu discusses two of his AMP 2024 presentations.
In this video, Dr. Zola N'Dandu...
09/17/2024
Vascular Disease Management
Dr Nakama
LINC 2024
BEST-CLI, BASIL-2 and Beyond: Bridging the Gap Between Our Daily Clinical Practice and Research Realities
05/30/2024

Tatsuya Nakama, MD
Tokyo Bay Medical Center, Japan

Tatsuya Nakama, MD Tokyo Bay Medical ...
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
The clinical realities of big...
05/30/2024
Vascular Disease Management
Dr Langhoff
LINC 2024
Atherectomy for Infrainguinal PAD?
05/29/2024

Ralf Langhoff
Sankt Gertrauden-Krankenhaus, Berlin, Germany

Ralf Langhoff Sankt Gertrauden-Kranke...
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Preliminary results from a...
05/29/2024
Vascular Disease Management
Dr Wittig
LINC 2024
New RCT Hopes to ‘CRACK-IT’ With Aggressive Vessel Prep in Heavily Calcified Fempop Lesions
05/29/2024

Tim Wittig, MD
University Hospital Leipzig, Germany

Tim Wittig, MD University Hospital Le...
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
An introduction to a new trial...
05/29/2024
Vascular Disease Management
Cath Lab Conversations
Podcasts
Cath Lab Conversations Podcast Episode List
04/17/2025
04/17/2025
Cath Lab Digest
Binita Shah, MD, FSCAI
SCAI 2025
SCAI 2025: Don't Miss This 5-Minute Program Overview!
04/17/2025
Binita Shah, MD, MS
SCAI 2025 Program Chair Binita Shah, MD, MS, FSCAI, shares some of the cutting-edge educational topics and enriching sessions planned for the meeting.
SCAI 2025 Program Chair Binita Shah, MD, MS, FSCAI, shares some of the cutting-edge educational topics and enriching sessions planned for the meeting.
SCAI 2025 Program Chair Binita...
04/17/2025
Cath Lab Digest
James B. Hermiller, MD, MSCAI
Radiation Safety
Radiation Safety and Occupational Safety
04/16/2025
James B. Hermiller, MD, FACC, MSCAI
Listen in as SCAI President James B. Hermiller, MD, MSCAI, shares more about his focus on radiation and occupational safety, and looks ahead to the upcoming SCAI Scientific Sessions, to be held May 1-3 in Washington, D.C.
Listen in as SCAI President James B. Hermiller, MD, MSCAI, shares more about his focus on radiation and occupational safety, and looks ahead to the upcoming SCAI Scientific Sessions, to be held May 1-3 in Washington, D.C.
Listen in as SCAI President...
04/16/2025
Cath Lab Digest
Arnold Seto, MD, MPA, Morton Kern, MD, and Bailey Estes, MSN
clinical trials discussion
4 Trials From ACC.25: ALT-SHOCK2, FLAVOUR-II, PROTECT-TAVI, and FAME 3
04/10/2025
Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI; Bailey Ann Estes, AGNP-C, MSN, RN-BC, RCIS, RNFA
Drs Mort Kern and Arnold Seto, and Bailey Estes, AGNP-C, discuss the results of 4 trials presented at ACC.25 and how decision making in the cath lab will be affected by the trial results.
Drs Mort Kern and Arnold Seto, and Bailey Estes, AGNP-C, discuss the results of 4 trials presented at ACC.25 and how decision making in the cath lab will be affected by the trial results.
Drs Mort Kern and Arnold Seto,...
04/10/2025
Cath Lab Digest
Srihari Naidu, MD
SCAI
Srihari Naidu, MD Talks About SCAI and His Upcoming Presidency
04/09/2025
Srihari S. Naidu, MD
Incoming SCAI President Srihari S. Naidu, MD, FSCAI, shares what he most values about the Society, his goals in founding the Emerging Leaders Mentorship (ELM) program, and plans for the upcoming year.
Incoming SCAI President Srihari S. Naidu, MD, FSCAI, shares what he most values about the Society, his goals in founding the Emerging Leaders Mentorship (ELM) program, and plans for the upcoming year.
Incoming SCAI President Srihari...
04/09/2025
Cath Lab Digest
Zola M. N'Dandu, MD
Research
We Must Mitigate Bias When Planning for PAD/CLTI Trials
04/04/2025
Zola N'Dandu, MD
How can we design peripheral arterial disease (PAD) and chronic limb-threatening ischemia (CLTI) trials that actually reflect the patients we treat every day? In his CRT 2025 presentation, Dr. Zola M. N'Dandu addressed the urgent need to...
How can we design peripheral arterial disease (PAD) and chronic limb-threatening ischemia (CLTI) trials that actually reflect the patients we treat every day? In his CRT 2025 presentation, Dr. Zola M. N'Dandu addressed the urgent need to...
How can we design peripheral...
04/04/2025
Cath Lab Digest
Morton J. Kern, MD, MSCAI
Clinical Trial Update
FLAVOUR II: A Brief Intro to the FFR and IVUS-Guided Intervention Strategy for Clinical Outcomes in Patients With Intermediate Stenosis
04/03/2025
Morton J. Kern, MD, MSCAI, FACC, FAHA
At CRT 2025 in Washington, D.C., Dr. Morton J. Kern discussed his prediction around the FLAVOUR II trial: would AI-driven angioFFR prove to be noninferior to intravascular ultrasound (IVUS) in guiding percutaneous coronary intervention for...
At CRT 2025 in Washington, D.C., Dr. Morton J. Kern discussed his prediction around the FLAVOUR II trial: would AI-driven angioFFR prove to be noninferior to intravascular ultrasound (IVUS) in guiding percutaneous coronary intervention for...
At CRT 2025 in Washington, D.C.,...
04/03/2025
Cath Lab Digest
Sacharias von Koch, MD
Drug-Coated Balloons
Real-World Usage of the Prevail Paclitaxel-Coated Balloon Compared with Other Contemporary Drug-Coated Balloons
04/02/2025
Sacharias von Koch, MD
Dr. Sacharias von Koch presented an analysis of data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) on the Prevail™ coronary paclitaxel drug-coated balloon (DCB) from Medtronic as a late-breaking clinical trial at...
Dr. Sacharias von Koch presented an analysis of data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) on the Prevail™ coronary paclitaxel drug-coated balloon (DCB) from Medtronic as a late-breaking clinical trial at...
Dr. Sacharias von Koch...
04/02/2025
Cath Lab Digest
Joachim Weil, MD
RF RDN
SPYRAL HTN-OFF and -ON MED 24-Month Results: BP Reductions After RF RDN
04/02/2025
Joachim Weil, MD
Joachim Weil, MD, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a...
Joachim Weil, MD, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a...
Joachim Weil, MD, presented a...
04/02/2025
Cath Lab Digest
Milner, Cilingiroglu, Inanc
Intravascular Imaging
Optical Coherence Tomography in Peripheral Arterial Disease Diagnosis and Treatment
04/01/2025
Thomas E. Milner, PhD; Mehmet Cilingiroglu, MD, FSCAI, FACC, FESC, FAHA; Ibrahim Halil Inanc, MD
Dr. Thomas Milner, Dr. Mehmet Cilingiroglu, and Dr. Ibrahim Halil Inanc explore the emerging role of intravascular optical coherence tomography (OCT) in the treatment of peripheral arterial disease (PAD).
Dr. Thomas Milner, Dr. Mehmet Cilingiroglu, and Dr. Ibrahim Halil Inanc explore the emerging role of intravascular optical coherence tomography (OCT) in the treatment of peripheral arterial disease (PAD).
Dr. Thomas Milner, Dr. Mehmet...
04/01/2025
Cath Lab Digest

CAse series
Intravascular Optical Coherence Tomography for the Diagnosis and Treatment of Peripheral Arterial Disease
04/04/2025
Mehmet Cilingiroglu, MD, FACC, FSCAI, FAHA, FESC, FACP; Thomas E. Milner, PhD; Ibrahim Halil Inanc, MD; Deniz Mutlu, MD; Konstantinos Marmagkiolis, MD, MBA, FACC, FSCAI; Cezar A. Iliescu, MD, FACC, FSCAI
In this case series, Cilingiroglu et al share their extensive experience in the use of OCT in daily clinical practice for PAD and CLTI cases as both a diagnostic and therapeutic tool.
In this case series, Cilingiroglu et al share their extensive experience in the use of OCT in daily clinical practice for PAD and CLTI cases as both a diagnostic and therapeutic tool.
In this case series,...
04/04/2025
Cath Lab Digest
Dr Ramon Varcoe
ISET 2025
The Role of Bioresorbable Stents in Tibial Disease: When and Where?
03/26/2025
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his...
03/26/2025
Vascular Disease Management
PAD and Heart Month
PAD Awareness
PAD Pulse Alliance Urges Screening for Disease Most Don’t Know They Have During American Heart Month
02/03/2025
“Too often, PAD isn’t caught until a patient is at risk of losing a limb. While treatment options have significantly advanced, it’s critical that more people know the signs and symptoms of PAD so they can seek treatment early, saving their...
“Too often, PAD isn’t caught until a patient is at risk of losing a limb. While treatment options have significantly advanced, it’s critical that more people know the signs and symptoms of PAD so they can seek treatment early, saving their...
“Too often, PAD isn’t caught...
02/03/2025
Cath Lab Digest
Dr Babaev
ISET 2025
Thirty-Day Outcomes From the Disrupt PAD BTK II Study
01/31/2025
Anvar Babaev, MD, PhD
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD,...
01/31/2025
Vascular Disease Management
Dr Kolluri
LINC 2025
The Case for Duplex Endpoints
01/29/2025
Raghu Kolluri, MS, MD, RVT, FSVM
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for...
01/29/2025
Vascular Disease Management
Dr Halena
LINC 2025
“Yes, you can always cross”: Simplified Retrograde Access for Superficial Femoral Artery Occlusions
01/29/2025
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations,...
01/29/2025
Vascular Disease Management
Case Report
Occluded Tibiopedal Access to Cross and Treat Complex Tibial Artery Occlusive Disease in a Patient With Critical Limb Ischemia
11/08/2024
Sreejit Nair, MD; Ashwani Sastry, MD; Janardhan Srinivasan, MD; Michael Canavan, DPM; Fadi Saab, MD, FACC, FSCAI; John H. Rundback, MD, FAHA, FSIR
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been...
11/08/2024
Vascular Disease Management
Interview
The Economic Costs and Patient Consequences of Amputation as a Treatment for Critical Limb Ischemia
09/19/2024
Mary Yost, MBA, president and cofounder of The Yost Group, spoke with VDM about her AMP 2024 presentation on the consequences of amputation as a treatment for patients with CLI.
Mary Yost, MBA, president and cofounder of The Yost Group, spoke with VDM about her AMP 2024 presentation on the consequences of amputation as a treatment for patients with CLI.
Mary Yost, MBA, president and...
09/19/2024
Vascular Disease Management
Dr Ramon Varcoe
AMP 2024
LIFE-BTK Further Analysis; 12-month RESOLV Data
09/18/2024
Ramon L. Varcoe, MBBS, MS, PhD
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP...
09/18/2024
Vascular Disease Management
Dr Thomas Zeller
AMP 2024
SPORTS: Drug-Eluting Stent or Primary Bare Nitinol Stent Application vs Drug-Coated Balloons in Long SFA Lesions; HEAL Study Update
09/18/2024
Thomas Zeller, MD, PhD
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller...
09/18/2024
Vascular Disease Management
Radiation Protection Systems
Rampart IC Secures Series B Financing to Fuel Strategic Growth and Expand Access to Radiation Safety Solutions
04/24/2025
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Rampart IC, a medical technology...
04/24/2025
Cath Lab Digest
Venous Leg Ulcers
Spectrum Venous Leg Ulcer Study Demonstrates Clinical Support for Use of VenaSeal™ in Advanced Superficial Venous Disease
04/24/2025
Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease Medtronic, the global leader in health care technology, today announced the primary and...
Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease Medtronic, the global leader in health care technology, today announced the primary and...
Results from study indicate...
04/24/2025
Vascular Disease Management
MEeting Update
SCAI Scientific Sessions 2025 Features Latest Clinical Innovations in Cardiology Care
04/24/2025
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.  
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.  
Whether you’re focused on...
04/24/2025
Cath Lab Digest
Scientific Statement
HRS and ACC Release Joint Scientific Statement on the Safety of Same-Day Discharge for Intracardiac Catheter Ablation Procedures
04/24/2025
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
This document draws on global...
04/24/2025
EP Lab Digest
Heart Disease Research
Link Between Heart Attack Severity and Circadian Rhythm Unveiled by UTHealth Houston Researchers
04/24/2025
“If you have a heart attack in the morning, you are more likely to have fatal arrhythmias, heart failure, and you’re more likely to die from it. The question we asked is ‘Why?’” said Holger Eltzschig, MD, PhD.
“If you have a heart attack in the morning, you are more likely to have fatal arrhythmias, heart failure, and you’re more likely to die from it. The question we asked is ‘Why?’” said Holger Eltzschig, MD, PhD.
“If you have a heart attack in...
04/24/2025
Cath Lab Digest
(Reproduced with permission from NEJM AI, Lampert, 2025. Copyright 2025 Massachusetts Medical Society)
AI: HCM
AI Algorithm Can Help Identify High-Risk Heart Patients to Quickly Diagnose, Expedite, and Improve Care
04/24/2025
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
Using the model to analyze...
04/24/2025
Cath Lab Digest
Peripheral Arterial Disease
Efemoral Medical Releases Positive Long-Term Results from EFEMORAL I
04/23/2025
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human...
04/23/2025
Cath Lab Digest
Large-Bore Vascular Closure
Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System
04/22/2025
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The PerQseal® Elite vascular...
04/22/2025
Cath Lab Digest
Lower-extremity intervention
First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using R3 Vascular's Magnitude Drug-Eluting Bioresorbable Scaffold
04/22/2025
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its...
04/22/2025
Cath Lab Digest
Uncontrolled Hypertension
Orchestra BioMed Receives FDA Breakthrough Device Designation for Atrioventricular Interval Modulation (AVIM) Therapy.
04/22/2025
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
“Patients at higher risk for...
04/22/2025
Cath Lab Digest

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use